Natural killer cells in healthy aging

Experimental Gerontology

Volumn 34, Issue 3, 1999, Pages 435-443

  Solana, R ^a   Alonso, M C ^a   Pena J ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Aging NK cells; CD16; CD56; Cytotoxicity; Immunosenescence

Indexed keywords

CYTOKINE; INTERLEUKIN 2; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; ARTICLE; CELL ACTIVATION; CELL KILLING; CELL PROLIFERATION; CELL STRAIN K 562; CYTOKINE RELEASE; CYTOTOXICITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; AGING; BIOLOGICAL MARKERS; CELL DIVISION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; PHENOTYPE;

EID: 0032976225     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(99)00008-X     Document Type: Article

References (47)

1. Baume D.M., Robertson M.J., Levine H., Manley T.J., Schow P.W., Ritz J. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur J Immunol. 22:1992;1-6.
2. Binstadt B.A., Brumbaugh K.M., Dick C.J. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 5:1996;629-638.
3. Borrego, F., Alonso, C., Galiani, M., (in press).
4. Borrego F., Pena J., Solana R. Regulation of CD69 expression on human natural killer cells Differential involvement of protein kinase C and protein tyrosine kinases . Eur J Immunol. 23:1993;1039-1043.
5. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA Class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187:1998;813-818.
6. Braud V.M., Allan D.S., O'Callaghan C.A. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (London). 391:1998;795-799.
7. Burshtyn D.N., Scharenberg A.M., Wagtmann N. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 4:1996;77-85.
8. Caligiuri M.A., Zmuidzinas A., Manley T.J., Smith K. Functional consequences of interleukin-2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med. 171:1990;150915-150915.
9. Carretero M., Palmieri G., Llano M. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A Evidence for receptor function in heterologous transfectants . Eur J Immunol. 28:1998;1280-1291.
10. Colonna M., Navarro F., Bellon T. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809-1818.
11. Cossarizza A., Ortolani C., Monti D., Franceschi C. Cytometric analysis of immunosenescence. Cytometry. 27:1997;297-313.
12. Edwards D.L., Avis F.P. Antibody-dependent cellular cytotoxicity effector cell capability among normal individuals. J Immunol. 123:1979;1887-1893.
13. Facchini A., Mariani E., Mariani A.R., Papa S., Vitale M., Manzoli F.A. Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin Exp Immunol. 68:1987;340-347.
14. Fernandes G., Gupta S. Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J Clin Immunol. 1:1981;141-148.
15. Franceschi C., Monti D., Sansoni P., Cossarizza A. The immunology of exceptional individuals the lesson of centenarians . Immunol Today. 16:1995;12-16.
16. Heller D.A., Ahern F.M., Stout J.T., Mcclearn G.E. Mortality and biomarkers of aging in heterogeneous stock (HS) mice. J Gerontol Ser A Biol Sci Med. 53:1998;B217-B230.
17. Krishnaraj R. Immunosenescence of human NK cells Effects on tumor target recognition, lethal hit and interferon sensitivity . Immunol Lett. 34:1992;79-84.
18. Krishnaraj R. Senescence and cytokines modulate the NK cell expression. Mech Ageing Dev. 96:1997;89-101.
19. Krishnaraj R., Bhooma T. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL2- induced interferon γ secretion. Immunol Lett. 50:1996;59-63.
20. Krishnaraj R., Svanborg A. Preferential accumulation of mature NK cells during human immunosenescence. J Cell Biochem. 50:1992;386-391.
21. Kutza J., Murasko D.M. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-α Cell Immunol. 155:1994;195-204.
22. Kutza J., Murasko D.M. Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech Ageing Dev. 90:1996;209-222.
23. Lanier L.L. NK cell receptors. Annu Rev Immunol. 16:1998;359-393.
24. Lanier L.L., Chang C., Phillips J.H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol. 153:1994;2417-2428.
25. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693-701.
26. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703-707.
27. Lanier L.L., Yu G., Phillips J.H. Co-association of CD3 ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. London) 342:1989;803-805.
28. Lopez-Botet M., Perez-Villar J.J., Carretero M. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev. 155:1997;165-174.
29. Mariani E., Mariani A.R., Meneghetti A., Tarozzi A., Cocco L., Facchini A. Age-dependent decreases of NK cell phosphoinisitide turnover during spontaneous but not Fc mediated cytolytic activity. Int Immunol. 10:1998;981-989.
30. Mariani E., Monaco M.C., Cattini L., Sinoppi M., Facchini A. Distribution and lytic activity of NK cell subsets in the elderly. Mech Ageing Dev. 76:1994;177-187.
31. Mariani E., Ravaglia G., Meneghetti A. Natural immunity and bone and muscle remodelling hormones in the ageing. Mech Ageing Dev. 102:1998;279-292.
32. Mariani E., Roda P., Mariani A.R. Age-associated changes in CD8+ and CD16+ cell reactivity Clonal analysis . Clin Exp Immunol. 81:1990;479-484.
33. Mariani E., Sgobbi S., Meneghetti A. Perforins in human cytolytic cells the effect of age . Mech Ageing Dev. 92:1996;195-209.
34. Moretta A., Biassoni R., Bottino C. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev. 155:1997;105-117.
35. Moretta A., Bottino C., Vitale M. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol. 14:1996;619-648.
36. Moretta A., Poggi A., Pende D. CD69-mediated pathway of lymphocyte activation Anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β J Exp Med. 174:1991;1393-1398.
37. Ogata K., Yokose N., Tamura H. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol. 84:1997;269-275.
38. Pawelec G., Remarque E., Barnett Y., Solana R. T cells and aging. Front Biosci. 3:1998;d59-d99.
39. Pawelec G., Remarque E., Mariani E., Solana R. Effect of ageing on innate immunity. J Leukoc Biol. 64:1998;703-712.
40. Pawelec G., Solana R. Immunosenescence. Immunol Today. 18:1997;514-516.
41. Rink L., Cakman I., Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev. 102:1998;199-210.
42. Sansoni P., Cossarizza A., Brianti V. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 82:1993;2767-2773.
43. Sivori S., Vitale M., Morelli L. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med. 186:1997;1129-1136.
44. Trinchieri G. Definition and biology of natural killer cells. Solana R., Pena J. MHC antigens and NK cells. 1994;1-15 R. G. Landes Co, Austin, TX.
45. Vitale M., Bottino C., Sivori S. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 187:1998;2065-2072.
46. Vitale M., Zamai L., Neri L.M. The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell Immunol. 145:1992;1-10.
47. Vivier E., Morin P.M., O'Brien C., Schlossman S.F., Anderson P. CD2 is functionally linked to the ζ-natural killer receptor complex. Eur J Immunol. 21:1991;1077-1080.